Near-IR-emitting
and/or efficiently photodynamic water-soluble Ru(II) complexes that
hold great application potentials as photodynamic therapy and/or photodetection
agents for cancers have been poorly explored. In this paper, the solvatochromism,
calf thymus DNA binding, and singlet oxygen generation properties
of a known ruthenium(II) complex of visible-emitting [Ru(bpy)2(dtdpq)](ClO4)2 (Ru1) and
a new homoleptic complex of near-IR-emitting [Ru(dtdpq)3](ClO4)2 (Ru2) (bpy = 2,2′-bipyridine,
dtdpq = 2,3-bis(thiophen-2-yl)pyrazino[2,3-f][1,10]phenanothroline)
in water are reported. Moreover, DNA photocleavage, singlet oxygen
generation in HeLa cells, cellular uptake/localization, and in vitro
photodynamic therapy for cancer cells of water-soluble Ru1 are described in detail. The results show that Ru1 acted
as potent photodynamic cancer therapy and mitochondrial imaging agents. Ru2 exhibited very strong solvatochromism from a visible emission
maximum at 588 nm in CH2Cl2 to the near-IR region
at 700 nm in water and singlet oxygen generation yield in water (23%)
and DNA binding properties (intercalative DNA binding constant on
the order of 106 M–1) comparable to those
of Ru1, which should make Ru2 attractive
for the aforementioned applications of Ru1 if the water
solubility of Ru2 can be improved enough for the studies
above.